Capital Wealth Alliance’s Amgen AMGN Stock Holding History

Capital Wealth Alliance’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16	Closed	-$3K	–	96
2019 Q4	$3K	Buy	+16	New	+$3.53K	﹤0.01%	272

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Wealth Alliance's AMGN Position: Q1 2020 in Review

Capital Wealth Alliance sold out of Amgen (AMGN) in Q1 2020, closing a stake of 16 shares — an estimated $3K sold.

Capital Wealth Alliance first reported a position in AMGN in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 2,030 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

Capital Wealth Alliance reported no remaining Amgen position as of Q1 2020 after selling out during the quarter.
Capital Wealth Alliance sold 16 Amgen shares in Q1 2020, an estimated $3K.
Capital Wealth Alliance first reported a position in Amgen in Q4 2019 and held it in 1 quarter.
Capital Wealth Alliance's Amgen position peaked at $3K in Q4 2019.
2,030 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Capital Wealth Alliance's 13F filing for Q1 2020, filed 28 Apr 2020.